Holen Sie sich die Stockscreener-App
0.7505
2.70%
-0.0208
Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.525
|
- | - | - | - |
| Operating Income/Loss |
33.21%
-3.525
|
-5.278 | -2.927 | -7.449 | -5.989 |
| Nonoperating Income/Loss |
111.95%
-0.18
|
1.506 | 0.032 | -0.109 | 0.423 |
| Income/Loss From Continuing Operations Before Tax |
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
|
Net Income/Loss
|
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
997.01%
54,588.28
|
4,976.08 | 24,386.01 | 18,836.48 | 13,453.15 |
| Diluted Average Shares |
997.01%
54,588.28
|
4,976.08 | 24,386.01 | 18,836.48 | 13,453.15 |
| Basic Earnings Per Share |
-
|
- | - | - | - |
| Diluted Earnings Per Share |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.71%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):